Investigación en Enfermidades Hematolóxicas
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublications in collaboration with researchers from University of Michigan–Ann Arbor (1)
2023
-
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1
Journal of Thrombosis and Haemostasis